These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1846672)

  • 1. Myristylation alters DNA-binding activity and transactivation of FBR (gag-fos) protein.
    Kamata N; Jotte RM; Holt JT
    Mol Cell Biol; 1991 Feb; 11(2):765-72. PubMed ID: 1846672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of myristylation on transrepression by FBR (Gag-Fos) protein.
    Kamata N; Holt JT
    Mol Cell Biol; 1992 Feb; 12(2):876-82. PubMed ID: 1310154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myristylation of FBR v-fos dictates the differentiation pathways in malignant osteosarcoma.
    Jotte RM; Holt JT
    J Cell Biol; 1996 Oct; 135(2):457-67. PubMed ID: 8896601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristylation-dependent transactivation by FBR v-fos is regulated by C/EBP.
    Jotte RM; Kamata N; Holt JT
    J Biol Chem; 1994 Jun; 269(23):16383-96. PubMed ID: 8206947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts.
    Steff AM; Carillo S; Pariat M; Piechaczyk M
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):685-92. PubMed ID: 9169601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals.
    Jamal S; Ziff E
    Nature; 1990 Mar; 344(6265):463-6. PubMed ID: 2157161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements.
    Gius D; Cao XM; Rauscher FJ; Cohen DR; Curran T; Sukhatme VP
    Mol Cell Biol; 1990 Aug; 10(8):4243-55. PubMed ID: 2115122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity.
    Nakabeppu Y; Nathans D
    Cell; 1991 Feb; 64(4):751-9. PubMed ID: 1900040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-dominant negative mutants of Fos and Jun.
    Ransone LJ; Visvader J; Wamsley P; Verma IM
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3806-10. PubMed ID: 2111017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional downregulation of the retina-specific QR1 gene by pp60v-src and identification of a novel v-src-responsive unit.
    Pierani A; Pouponnot C; Calothy G
    Mol Cell Biol; 1993 Jun; 13(6):3401-14. PubMed ID: 8388536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
    Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
    Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of v-raf-dependent c-fos expression and transformation by a kinase-defective mutant of the mitogen-activated protein kinase Erk2.
    Kortenjann M; Thomae O; Shaw PE
    Mol Cell Biol; 1994 Jul; 14(7):4815-24. PubMed ID: 8007980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.
    Hagman J; Grosschedl R
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8889-93. PubMed ID: 1409581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and viral Fos proteins are degraded by different proteolytic systems.
    Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
    Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gag sequence in the biochemical properties and transforming activity of the avian sarcoma virus UR2-encoded gag-ros fusion protein.
    Jong SM; Wang LH
    J Virol; 1990 Dec; 64(12):5997-6009. PubMed ID: 2173777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product.
    Curran T; Verma IM
    Virology; 1984 May; 135(1):218-28. PubMed ID: 6203214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of proenkephalin by Fos and Jun.
    Sonnenberg JL; Rauscher FJ; Morgan JI; Curran T
    Science; 1989 Dec; 246(4937):1622-5. PubMed ID: 2512642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant.
    Kaplan JM; Mardon G; Bishop JM; Varmus HE
    Mol Cell Biol; 1988 Jun; 8(6):2435-41. PubMed ID: 2841581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and expression of linker insertion and site-directed mutants of v-fps protein-tyrosine kinase.
    Stone JC; Moran MF; Pawson T
    Methods Enzymol; 1991; 200():673-92. PubMed ID: 1659662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.